Is loss of ezrin in human intrahepatic cholangiocarcinoma associated with ectopic expression of E-cadherin?
Ezrin is down-regulated during cholangiocarcinogenesis, and its loss results in a more aggressive phenotype.
Association of the low avidity HPV16 antibody "phenotype" with possible susceptibility to infections with other HPV types warrants investigation.